Compugen Ltd

Penny Stocks Biotech Stocks Healthcare Stocks

$2.20

+0.07 (+3.29%)

As of Apr 1, 10:08 PM ET ·

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 10 91%

Hold 1 9%

Sell 0 0%

Price Target

Analyst Price Target +2,011.8% upside

Low Target $33.82

Average Target $46.46

High Target $60.35

Current Price $2.20

Current
$2.20

Target
$46.46

$33.82 $46.46 avg $60.35

Scenario Analysis

Bear Case

$33.82

1,437.3%

Low target

Base Case

$46.46

+2,011.8%

Avg target

Bull Case

$60.35

+2,643.2%

High target

Risk/Reward

1.8x

Balanced

Price in Context

52-Week High

$2.38

-7.6% from high

52-Week Low

$1.13

+94.7% from low

Target vs 52W High

$46.46

+1,852.1% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Buy	39	69%	$257.58	+19.8%
AMGN Amgen Inc	Hold	42	50%	$190.87	-46.0%
GILD Gilead Sciences Inc	Strong Buy	38	79%	$362.68	+158.5%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	39	79%	$438.34	-2.0%
REGN Regeneron Pharmaceuticals	Strong Buy	36	75%	$76.80	-90.1%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	36	78%	$102.31	-68.9%
INSM Insmed Inc	Strong Buy	26	92%	$143.40	-13.0%
NTRA Natera Inc	Strong Buy	27	89%	$142.91	-29.7%